CRNX icon

Crinetics Pharmaceuticals

71 hedge funds and large institutions have $475M invested in Crinetics Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

62% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 13

Holders
71
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$1.98M
2 +$1.84M
3 +$1.81M
4
Goldman Sachs
Goldman Sachs
New York
+$1.37M
5
NHAS
Novo Holdings A/S
Denmark
+$892K

Top Sellers

1 -$15.1M
2 -$3.07M
3 -$3.06M
4
Morgan Stanley
Morgan Stanley
New York
-$2.71M
5
Millennium Management
Millennium Management
New York
-$1.98M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$77.3M
2
$57.3M
3
$43.1M
4
$36.5M
5
$35.5M
6
$31.8M
7
$28.2M
8
$21.3M
9
$21.1M
10
$16.9M
11
$16.8M
12
$13.7M
13
$8.02M
14
$6.95M
15
$6.86M
16
$5.1M
17
$4.88M
18
$4.74M
19
$4.25M
20
$3.78M
21
$3.76M
22
$2.81M
23
$2.78M
24
$2.3M
25
$2.21M